Oncolytics Biotech Inc.
ONCY
Price:
$0.803
Market Cap:
$112.71M
Oncolytics Biotech Inc. is a biopharmaceutical firm in its development phase, concentrating its efforts on discovering and creating novel pharmaceutical agents to combat cancer. Its primary therapeutic candidate is pelareorep, an immunotherapeutic drug delivered intravenously, designed to target and treat both solid tumors and various blood-related cancers. The company has established strategic co-development agreements with major pharmaceutical companies, Merck KGaA and Pfizer Inc., as well as with PrECOG LLC. These collaborations are focused on advancing pelareorep for use in conjunction with paclitaxel and avelumab (a human anti-PD-L1 antibody). This specific combination therapy is being ...[Read more]
Industry
Biotechnology
IPO Date
2001-10-05
Stock Exchange
NASDAQ
Ticker
ONCY
PE Ratio
[-2.51]
ROE
[5.21%]
Current Ratio
[1.38]
Dividend Yield
[0%]
Enterprise Value
[107.73M]
Dividend History
The ROE as of June 2026 (TTM) for Oncolytics Biotech Inc. (ONCY) is 5.21%
According to Oncolytics Biotech Inc.’s latest financial reports and current stock price. The company's current ROE is 5.21%. This represents a change of -269.33% compared to the average of -3079.32% of the last 4 quarters.
Oncolytics Biotech Inc. (ONCY) Historical ROE (quarterly & annually)
How has ONCY ROE performed in the past?
The mean historical ROE of Oncolytics Biotech Inc. over the last ten years is 4.16%. The current 5.21% ROE has changed 25.44% with respect to the historical average. Over the past ten years (40 quarters), ONCY's ROE was at its highest in in the December 2019 quarter at 17.98%. The ROE was at its lowest in in the September 2025 quarter at -12521.74%.
Average
4.16%
Median
-73.29%
Minimum
-530.00%
Maximum
42.22%
Oncolytics Biotech Inc. (ONCY) ROE by Quarter and Year
Discovering the peaks and valleys of Oncolytics Biotech Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 610.46%
Maximum Annual ROE = 42.22%
Minimum Annual Increase = -15452.60%
Minimum Annual ROE = -530.00%
| Year | ROE | Change |
|---|---|---|
| 2025 | 757.02% | -242.83% |
| 2024 | -530.00% | 610.46% |
| 2023 | -74.60% | 3.64% |
| 2022 | -71.98% | 23.85% |
| 2021 | -58.12% | -14.26% |
| 2020 | -67.78% | -100.16% |
| 2019 | 42.22% | -15452.60% |
| 2018 | -275.00% | 45.87% |
| 2017 | -188.52% | 33.11% |
| 2016 | -141.63% | 154.66% |
Oncolytics Biotech Inc. (ONCY) Average ROE
How has ONCY ROE performed in the past?
The current ROE of Oncolytics Biotech Inc. (ONCY) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
50.80%
5-year avg
4.46%
10-year avg
4.16%
Oncolytics Biotech Inc. (ONCY) ROE vs. Peers
How is ONCY’s ROE compared to its peers?
Oncolytics Biotech Inc.’s ROE is greater than Atossa Therapeutics, Inc. (-84.91%), greater than Immix Biopharma, Inc. (-73.23%), greater than Whitehawk Therapeutics Inc (-79.63%), greater than Instil Bio, Inc. (-39.76%), greater than Zentalis Pharmaceuticals, Inc. (-53.61%), greater than MacroGenics, Inc. (-147.80%), less than Tevogen Bio Holdings Inc. (241.39%), greater than Coya Therapeutics, Inc. (-57.26%), less than Clene Inc. (233.93%), less than Surrozen, Inc. (309.79%),
| Company | ROE | Market cap |
|---|---|---|
| -84.91% | $21.18M | |
| -73.23% | $459.70M | |
| -79.63% | $205.72M | |
| -39.76% | $53.71M | |
| -53.61% | $266.95M | |
| -147.80% | $251.71M | |
| 241.39% | $43.84M | |
| -57.26% | $86.31M | |
| 233.93% | $60.20M | |
| 309.79% | $174.90M |
Build a custom stock screener for Oncolytics Biotech Inc. (ONCY) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncolytics Biotech Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Oncolytics Biotech Inc. (ONCY) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Oncolytics Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Oncolytics Biotech Inc.'s ROE?
How is the ROE calculated for Oncolytics Biotech Inc. (ONCY)?
What is the highest ROE for Oncolytics Biotech Inc. (ONCY)?
What is the 3-year average ROE for Oncolytics Biotech Inc. (ONCY)?
What is the 5-year average ROE for Oncolytics Biotech Inc. (ONCY)?
How does the current ROE for Oncolytics Biotech Inc. (ONCY) compare to its historical average?